NEW YORK (GenomeWeb News) – Exact Sciences has received notice from the Nasdaq Stock Market that it is not in compliance with the Nasdaq Global Market’s listing’s requirement of a minimum $40 million market capitalization, the company said today.
 
Exact Sciences’ market cap is currently $36.4 million.
 
The company has 30 calendar days, or until Aug. 11, to regain compliance by maintaining a minimum $50 million market value for at least 10 consecutive business days.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

23andMe's Anne Wojcicki ponders DNA and what it means to be human in a New York Times essay.

A new estimate places the last universal common ancestor to life on Earth as living 3.9 billion years ago, Inverse reports.

In PNAS this week: retinitis pigmentosa gene therapy, role of microbiome in growth stunting, and more.

Bloomberg reports that researchers and drug companies are modeling anti-obesity treatments after the rare genetic condition essential fructosuria.